<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Lee MS</submitter><funding>Ministry of Science, ICT and Future Planning</funding><funding>National Research Foundation of Korea</funding><pagination>452-467</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10101799</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>55(2)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>NUT carcinoma (NC) is a solid tumor caused by the rearrangement of NUTM1 that usually develops in midline structures, such as the thorax. No standard treatment has been established despite high lethality. Thus, we investigated whether targeting the junction region of NUTM1 fusion breakpoints could serve as a potential treatment option for NC.&lt;h4>Materials and methods&lt;/h4>We designed and evaluated a series of small interfering RNAs (siRNAs) targeting the junction region of BRD4-NUTM1 fusion (B4N), the most common form of NUTM1 fusion. Droplet digital polymerase chain reaction using the blood of patients was also tested to evaluate the treatment responses by the junction sequence of the B4N fusion transcripts.&lt;h4>Results&lt;/h4>As expected, the majority of NC fusion types were B</pubmed_abstract><journal>Cancer research and treatment</journal><pubmed_title>Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.</pubmed_title><pmcid>PMC10101799</pmcid><funding_grant_id>2022R1A2C2006322</funding_grant_id><funding_grant_id>2021R1A2C4002158</funding_grant_id><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Chang ES</pubmed_authors><pubmed_authors>Jung K</pubmed_authors><pubmed_authors>Lee SH</pubmed_authors><pubmed_authors>Choi J</pubmed_authors><pubmed_authors>Jeon YK</pubmed_authors><pubmed_authors>Lakshmi C</pubmed_authors><pubmed_authors>Park S</pubmed_authors><pubmed_authors>Sung M</pubmed_authors><pubmed_authors>Choi YL</pubmed_authors><pubmed_authors>Lee MS</pubmed_authors><pubmed_authors>Oh DY</pubmed_authors><pubmed_authors>Song JY</pubmed_authors><pubmed_authors>Han J</pubmed_authors><pubmed_authors>An S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Cancer-Specific Sequences in the Diagnosis and Treatment of NUT Carcinoma.</name><description>&lt;h4>Purpose&lt;/h4>NUT carcinoma (NC) is a solid tumor caused by the rearrangement of NUTM1 that usually develops in midline structures, such as the thorax. No standard treatment has been established despite high lethality. Thus, we investigated whether targeting the junction region of NUTM1 fusion breakpoints could serve as a potential treatment option for NC.&lt;h4>Materials and methods&lt;/h4>We designed and evaluated a series of small interfering RNAs (siRNAs) targeting the junction region of BRD4-NUTM1 fusion (B4N), the most common form of NUTM1 fusion. Droplet digital polymerase chain reaction using the blood of patients was also tested to evaluate the treatment responses by the junction sequence of the B4N fusion transcripts.&lt;h4>Results&lt;/h4>As expected, the majority of NC fusion types were B</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Apr</publication><modification>2026-07-14T22:25:27.962Z</modification><creation>2025-02-19T04:16:30.994Z</creation></dates><accession>S-EPMC10101799</accession><cross_references><pubmed>36265509</pubmed><doi>10.4143/crt.2022.910</doi></cross_references></HashMap>